» Articles » PMID: 37512047

A Review of Treatment Methods Focusing on Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation for Chronic Spinal Cord Injury

Overview
Publisher MDPI
Specialty General Medicine
Date 2023 Jul 29
PMID 37512047
Authors
Affiliations
Soon will be listed here.
Abstract

Cell transplantation therapy using human induced pluripotent stem cell-derived neural stem/progenitor cells (hiPSC-NS/PCs) has attracted attention as a regenerative therapy for spinal cord injury (SCI), and its efficacy in treating the subacute phase of SCI has been reported in numerous studies. However, few studies have focused on treatment in the chronic phase, which accounts for many patients, suggesting that there are factors that are difficult to overcome in the treatment of chronic SCI. The search for therapeutic strategies that focus on chronic SCI is fraught with challenges, and the combination of different therapies is thought to be the key to a solution. In addition, many issues remain to be addressed, including the investigation of therapeutic approaches for more severe injury models of chronic SCI and the acquisition of practical motor function. This review summarizes the current progress in regenerative therapy for SCI and discusses the prospects for regenerative medicine, particularly in animal models of chronic SCI.

Citing Articles

Induced Neural Stem Cell Transplantation in Spinal Cord Injury: Present Status and Next Steps.

Jung J, Jeong J, Ko M, Lee B, Kwon W, Jeon S Korean J Neurotrauma. 2025; 20(4):234-245.

PMID: 39803345 PMC: 11711022. DOI: 10.13004/kjnt.2024.20.e45.


Human induced pluripotent stem cell-derived therapies for regeneration after central nervous system injury.

Vidman S, Ma Y, Fullenkamp N, Plant G Neural Regen Res. 2024; 20(11):3063-3075.

PMID: 39715081 PMC: 11881715. DOI: 10.4103/NRR.NRR-D-24-00901.


Cell therapy for neurological disorders.

Svendsen S, Svendsen C Nat Med. 2024; 30(10):2756-2770.

PMID: 39407034 DOI: 10.1038/s41591-024-03281-3.


Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury.

Winn D, Uhlin E, Kele M, Eidhof I, Falk A Front Pharmacol. 2024; 15:1390058.

PMID: 38841365 PMC: 11150580. DOI: 10.3389/fphar.2024.1390058.


Human stem cell transplantation models of Alzheimer's disease.

Ifediora N, Canoll P, Hargus G Front Aging Neurosci. 2024; 16:1354164.

PMID: 38450383 PMC: 10915253. DOI: 10.3389/fnagi.2024.1354164.

References
1.
Shibata R, Nagoshi N, Kajikawa K, Ito S, Shibata S, Shindo T . Administration of C5a Receptor Antagonist Improves the Efficacy of Human Induced Pluripotent Stem Cell-Derived Neural Stem/Progenitor Cell Transplantation in the Acute Phase of Spinal Cord Injury. J Neurotrauma. 2022; 39(9-10):667-682. DOI: 10.1089/neu.2021.0225. View

2.
Wang D, Ichiyama R, Zhao R, Andrews M, Fawcett J . Chondroitinase combined with rehabilitation promotes recovery of forelimb function in rats with chronic spinal cord injury. J Neurosci. 2011; 31(25):9332-44. PMC: 6623473. DOI: 10.1523/JNEUROSCI.0983-11.2011. View

3.
Shibata T, Tashiro S, Shinozaki M, Hashimoto S, Matsumoto M, Nakamura M . Treadmill training based on the overload principle promotes locomotor recovery in a mouse model of chronic spinal cord injury. Exp Neurol. 2021; 345:113834. DOI: 10.1016/j.expneurol.2021.113834. View

4.
Shinozaki M, Nagoshi N, Nakamura M, Okano H . Mechanisms of Stem Cell Therapy in Spinal Cord Injuries. Cells. 2021; 10(10). PMC: 8534136. DOI: 10.3390/cells10102676. View

5.
Keyvan-Fouladi N, Raisman G, Li Y . Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci. 2003; 23(28):9428-34. PMC: 6740581. View